Through proteomic and GO analyses, we found that the upregulated proteins p62 and LC3B in the autophagy pathway were enriched after CAPE treatment, indicating that CAPE may exert its drug-sensitizing effects by regulating autophagy in colon cancer cells. This evidence concerns the gene SQSTM1 and colonic neoplasm.